Form 8.3 - Horizon Therapeutics plc

LONDON, February 01, 2023--(BUSINESS WIRE)--

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BQPVQZ61

Date of dealing

31st January 2023

2. INTERESTS AND SHORT POSITIONS

a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

4,508,173

(1.971%)

43,323

(0.019%)

(2) Derivatives (other than options)

621

(0.000%)

(3) Options and agreements to purchase/sell

75,000

(0.033%)

151,700

(0.066%)

Total

4,583,173

(2.003%)

195,644

(0.086%)

b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Ap20

1. DEALINGS (Note 4)

a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

Purchase

46

109.80

Purchase

13

110.44

Purchase

1,345

109.79

Purchase

9

109.75

Purchase

13

109.86

Purchase

11

110.20

Sale

2

110.20

Purchase

586

110.19

Purchase

10

110.05

Purchase

201

110.11

Purchase

959

109.74

Purchase

143

110.00

Purchase

8,923

110.02

Purchase

10

109.94

Purchase

300

109.93

Purchase

734

109.97

Purchase

156

110.03

Purchase

410

109.89

Purchase

1,107

110.14

Purchase

400

109.90

Purchase

109

109.81

Purchase

6,299

109.76

Purchase

3,944

109.72

Purchase

278

109.71

Purchase

100

109.99

Purchase

267

109.98

Purchase

757

109.92

Purchase

814

109.77

Purchase

1,953

109.78

Purchase

3

109.67

Purchase

844

109.63

Purchase

19

109.64

Purchase

1,590

109.73

Purchase

31

109.96

Purchase

6

109.61

Purchase

100

110.50

Purchase

487

110.48

Purchase

42

110.49

Purchase

1

109.56

Purchase

3

109.66

Purchase

54

110.10

Purchase

486

109.69

Purchase

270

110.46

Purchase

163

110.40

Purchase

1,660

109.13

Purchase

1

109.49

Purchase

2

109.80

Purchase

86

110.23

Purchase

89

110.25

Purchase

2

110.20

Purchase

133

110.19

Purchase

81

110.21

Purchase

87

110.37

Purchase

86

110.29

Purchase

57

109.74

Sale

34

110.07

Purchase

45

109.93

Purchase

1

109.97

Purchase

87

110.13

Purchase

160

110.15

Sale

20

110.14

Purchase

49

109.95

Sale

73

109.81

Purchase

44

109.68

Sale

1,759

109.72

Purchase

1

109.71

Purchase

668

109.70

Purchase

45

109.85

Purchase

1

109.63

Purchase

87

109.57

Purchase

300

110.28

Purchase

2

109.61

Purchase

40

110.51

Purchase

218

110.50

Purchase

129

110.26

Purchase

2,490

109.69

Purchase

1

110.58

Sale

44

109.68

Purchase

45

109.72

Sale

1

110.58

Purchase

100

109.80

Sale

3,102

109.80

Purchase

200

109.84

Sale

120

109.84

Purchase

423

110.44

Purchase

386

109.79

Sale

2,418

109.79

Sale

50

109.45

Purchase

1,300

110.01

Sale

6,953

110.01

Sale

1,599

109.75

Sale

1,116

109.53

Purchase

3,974

108.71

Sale

5,314

109.86

Purchase

719

110.23

Sale

5,734

110.23

Purchase

265

110.47

Sale

230

110.12

Purchase

1,103

110.25

Sale

1,225

110.25

Purchase

2,059

110.20

Sale

901

110.20

Sale

800

110.39

Purchase

190

110.06

Sale

8,493

110.06

Purchase

69

110.19

Sale

600

110.19

Purchase

60

109.87

Sale

5,953

109.87

Purchase

3,316

110.05

Sale

3,871

110.05

Purchase

30

110.04

Sale

2,612

110.04

Purchase

156

110.11

Purchase

652

110.21

Sale

800

110.21

Purchase

810

109.91

Sale

2,952

109.91

Purchase

2,300

108.91

Sale

1,519

108.74

Purchase

246

110.24

Purchase

1,225

110.17

Sale

1,000

110.33

Purchase

900

110.34

Sale

500

110.34

Purchase

105

110.27

Purchase

1,447

110.18

Sale

2,798

110.18

Purchase

624

110.22

Sale

641

110.22

Sale

2,205

109.74

Purchase

10

110.32

Sale

192

110.32

Purchase

426

110.07

Sale

200

110.07

Purchase

742

110.00

Sale

7,601

110.00

Purchase

10

110.02

Sale

3,546

110.02

Sale

82

110.16

Purchase

1,558

109.94

Sale

1,135

109.94

Purchase

433

109.93

Sale

930

109.93

Purchase

1,105

109.97

Sale

1,192

109.97

Purchase

6,528

110.13

Sale

3,806

110.13

Sale

854

110.08

Purchase

2,471

110.15

Sale

2,583

110.15

Purchase

3,600

110.03

Sale

1,734

110.03

Sale

495

109.89

Purchase

11

110.14

Sale

4,968

110.14

Purchase

433

109.95

Sale

926

109.95

Purchase

189

109.90

Sale

1,567

109.90

Purchase

240

110.09

Sale

587

110.09

Purchase

311

109.81

Sale

4,575

109.81

Sale

11,856

109.76

Purchase

1,412

109.68

Sale

652

109.68

Purchase

1,093

109.72

Sale

666

109.72

Purchase

300

109.71

Sale

3,181

109.71

Purchase

13,945

109.70

Sale

752

109.70

Purchase

401

109.99

Sale

338

109.99

Purchase

105

109.98

Sale

645

109.98

Purchase

951

109.92

Sale

1,539

109.92

Purchase

100

109.85

Sale

2,213

109.85

Purchase

334

109.88

Sale

2,222

109.88

Purchase

101

109.82

Sale

1,400

109.82

Sale

846

109.77

Sale

1,646

109.78

Sale

250

109.65

Purchase

601

109.59

Sale

620

109.59

Purchase

1,002

109.62

Sale

100

109.62

Purchase

927

109.67

Sale

539

109.67

Sale

10,100

109.63

Purchase

1

109.60

Sale

2,247

109.60

Purchase

766

109.64

Sale

1,700

109.64

Purchase

853

109.73

Sale

1,578

109.73

Sale

310

109.57

Purchase

105

109.83

Sale

300

109.83

Purchase

3,032

110.28

Sale

10,600

110.28

Purchase

1,720

110.43

Sale

950

109.96

Purchase

918

109.61

Sale

202

109.61

Purchase

700

110.50

Purchase

545

110.48

Purchase

300

110.49

Purchase

920

109.52

Sale

410

109.52

Sale

100

109.54

Sale

1,308

109.58

Sale

50

109.47

Sale

700

109.56

Sale

1,000

110.30

Purchase

1,640

108.88

Purchase

600

110.26

Sale

400

110.26

Purchase

3,534

108.90

Purchase

1,092

109.20

Purchase

1,737

108.77

Sale

210

109.66

Sale

1,200

110.31

Purchase

100

108.61

Sale

50

108.61

Purchase

14,224

110.10

Sale

10,258

110.10

Purchase

4,500

109.55

Sale

100

109.55

Purchase

4,890

109.50

Sale

1,074

109.50

Sale

200

109.51

Sale

16,600

109.43

Purchase

905

110.52

Sale

905

110.52

Purchase

6,896

109.69

Sale

3,360

109.69

Sale

200

108.34

Purchase

2,259

108.75

Sale

3,865

108.65

Sale

500

108.42

Purchase

263

108.85

Purchase

696

108.89

Purchase

800

109.08

Sale

100

108.29

Sale

321

108.39

Purchase

1,293

110.46

Purchase

203

110.40

Purchase

400

108.57

Purchase

100

108.83

Purchase

5,913

108.64

Sale

4,629

108.64

Purchase

176

108.82

Purchase

3,600

108.73

Purchase

3,935

108.67

Sale

300

108.49

Purchase

700

109.14

Purchase

568

109.38

Purchase

2,900

108.58

Purchase

101

110.45

Sale

300

108.50

Purchase

6,250

108.62

Sale

737

108.62

Purchase

2,091

108.84

Purchase

3,658

109.07

Sale

2,600

109.42

Purchase

100

108.86

Purchase

500

108.60

Sale

299

108.68

Sale

1,381

108.72

Sale

1,531

108.43

Sale

77

108.51

Sale

1,756

108.22

Sale

306

108.25

Sale

100

108.07

Sale

791

109.87

Purchase

127

109.89

Sale

8,873

109.89

Purchase

9,606

109.64

b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

c) Options transactions in respect of existing relevant securities

i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Put option

Selling

133,900

110.00

American

2/17/2023

Put Option

Purchasing

80.00

80.00

American

1/17/2025

ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

1st February 2023

Contact name

Roisin Nagle

Telephone number

+44 203 192 8746

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making
disclosure:

Millennium International Management LP

Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates:

Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of
relevant
security

Product
description
e.g. call
option

Written or
purchased

Number of
securities to
which option
or derivative
relates

Exercise
price
per unit

Type
e.g.
American,
European
etc.

Expiry
date

IE00BQPVQZ61

Call Option

Written

29,000

110.00

American

2/17/2023

IE00BQPVQZ61

Call Option

Purchased

29,100

100.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

1,500

90.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

3,000

110.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Written

3,000

115.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

42,500

120.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

400

115.00

American

3/17/2023

IE00BQPVQZ61

Put Option

Purchased

400

115.00

American

3/17/2023

IE00BQPVQZ61

Put Option

Purchased

3,500

110.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

62,400

110.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

4,100

80.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

3,500

110.00

American

3/17/2023

IE00BQPVQZ61

Put Option

Purchased

3,100

85.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

2,500

90.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

100

95.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

23,800

100.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

14,500

105.00

American

2/17/2023

IE00BQPVQZ61

Put Option

Purchased

300

80.00

American

1/17/2025

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230201005719/en/

Contacts

Millennium Partners, L.P.